CORRECTED-Pfizer to buy two Baxter vaccines for $635 mln

Wed Jul 30, 2014 9:09am EDT

(Corrects third paragraph to " ... outside the United States" from " ... in the United States")

July 30 (Reuters) - Pfizer Inc agreed to buy two of Baxter International Inc's vaccines and a part of a facility involved in their production for $635 million.

The deal will give Pfizer access to Baxter's NeisVac-C, a meningitis vaccine, and FSME-IMMUN, an encephalitis vaccine.

Both vaccines are already being sold outside the United States. (Reporting by Anand Basu; Editing by Simon Jennings)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.